To induce diverse de novo tumorigenesis, we made use of the archetypal Trp53−/− (also known as p53−/−) genotype, whereby STSs and lymphomas form in p53−/− mice at a high frequency and within six months62,63. Here, TP53 is linked to lymphoma.